159 related articles for article (PubMed ID: 29381660)
1. Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey.
Pacello P; Baccaro LF; Pedro AO; Costa-Paiva L
Menopause; 2018 Jun; 25(6):683-690. PubMed ID: 29381660
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with knowledge about menopause and hormone therapy in middle-aged Brazilian women: a population-based household survey.
de Arruda Amaral ICG; Baccaro LF; Lui-Filho JF; Osis MJD; Pedro AO; Costa-Paiva L
Menopause; 2018 Jul; 25(7):803-810. PubMed ID: 29939892
[TBL] [Abstract][Full Text] [Related]
3. Type of menopause, patterns of hormone therapy use, and hot flashes.
Gallicchio L; Whiteman MK; Tomic D; Miller KP; Langenberg P; Flaws JA
Fertil Steril; 2006 May; 85(5):1432-40. PubMed ID: 16566933
[TBL] [Abstract][Full Text] [Related]
4. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
5. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
6. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
7. [Factors associated with menopausal symptoms in women from a metropolitan region in Southeastern Brazil: a population-based household survey].
Lui Filho JF; Baccaro LF; Fernandes T; Conde DM; Costa-Paiva L; Pinto Neto AM
Rev Bras Ginecol Obstet; 2015 Apr; 37(4):152-8. PubMed ID: 25992497
[TBL] [Abstract][Full Text] [Related]
8. Factors determining the use of hormonal therapy and phytotherapy in Spanish postmenopausal women.
Mendoza N; Hernández C; Cornellana MJ; Carballo A; Llaneza P; Harvey X; Palacios S;
Climacteric; 2016 Aug; 19(4):375-80. PubMed ID: 27174039
[TBL] [Abstract][Full Text] [Related]
9. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
Parazzini F;
Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
[TBL] [Abstract][Full Text] [Related]
11. [Factors associated with the intensity of hot flashes in climacteric women].
Santos-Sá D; Pinto-Neto AM; Conde DM; Pedro AO; Oliveira SC; Costa-Paiva L
Rev Assoc Med Bras (1992); 2006; 52(6):413-8. PubMed ID: 17242778
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey.
Islam RM; Bell RJ; Billah B; Hossain MB; Davis SR
Menopause; 2016 Jul; 23(7):731-9. PubMed ID: 26926325
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and attitude towards menopause and hormone replacement therapy in Chinese women.
Jin F; Tao M; Teng Y; Shao H; Li C; Mills E
Gynecol Obstet Invest; 2015; 79(1):40-5. PubMed ID: 25277502
[TBL] [Abstract][Full Text] [Related]
14. Shared decision-making on the use of hormone therapy: a nationwide survey in the Republic of Korea.
An AR; Shin DW; Chun SH; Lee HK; Ko YJ; Lee H; Son KY; Choi HC; Cho B; Lee JK; Kim JG
Menopause; 2014 Jul; 21(7):726-31. PubMed ID: 24378764
[TBL] [Abstract][Full Text] [Related]
15. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women.
Worsley R; Bell RJ; Gartoulla P; Davis SR
Menopause; 2016 Jan; 23(1):11-7. PubMed ID: 26240945
[TBL] [Abstract][Full Text] [Related]
16. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
Gartoulla P; Worsley R; Bell RJ; Davis SR
Menopause; 2015 Jul; 22(7):694-701. PubMed ID: 25706184
[TBL] [Abstract][Full Text] [Related]
17. Symptoms, health behavior and understanding of menopause therapy in women with premature menopause.
Gibson-Helm M; Teede H; Vincent A
Climacteric; 2014 Dec; 17(6):666-73. PubMed ID: 24742007
[TBL] [Abstract][Full Text] [Related]
18. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.
Oppermann K; Fuchs SC; Donato G; Bastos CA; Spritzer PM
Menopause; 2012 Mar; 19(3):355-60. PubMed ID: 21971211
[TBL] [Abstract][Full Text] [Related]
19. Practice patterns with hormone therapy after surgical menopause.
Chubaty A; Shandro MT; Schuurmans N; Yuksel N
Maturitas; 2011 May; 69(1):69-73. PubMed ID: 21396791
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, severity, and associated factors of menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study in southeast China.
Lan Y; Huang Y; Song Y; Ma L; Chen P; Ying Q; Li W; Cai Y; Zhou J
Menopause; 2017 Oct; 24(10):1200-1207. PubMed ID: 28609386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
